Glutamate Transporter-Dependent mTOR Phosphorylation in Müller Glia Cells

Abstract

Glu (glutamate), the excitatory transmitter at the main signalling pathway in the retina, is critically involved in changes in the protein repertoire through the activation of signalling cascades, which regulate protein synthesis at transcriptional and translational levels. Activity-dependent differential gene expression by Glu is related to the activation of ionotropic and metabotropic Glu receptors; however, recent findings suggest the involvement of Na⁺-dependent Glu transporters in this process. Within the retina, Glu uptake is aimed at the replenishment of the releasable pool, and for the prevention of excitotoxicity and is carried mainly by the GLAST/EAAT-1 (Na⁺-dependent glutamate/aspartate transporter/excitatory amino acids transporter-1) located in Müller radial glia. Based on the previous work showing the alteration of GLAST expression induced by Glu, the present work investigates the involvement of GLAST signalling in the regulation of protein synthesis in Müller cells. To this end, we explored the effect of D-Asp (D-aspartate) on Ser-2448 mTOR (mammalian target of rapamycin) phosphorylation in primary cultures of chick Müller glia. The results showed that D-Asp transport induces the time- and dose-dependent phosphorylation of mTOR, mimicked by the transportable GLAST inhibitor THA (threo-β-hydroxyaspartate). Signalling leading to mTOR phosphorylation includes Ca²⁺ influx, the activation of p60^src, phosphatidylinositol 3-kinase, protein kinase B, mTOR and p70^S6K. Interestingly, GLAST activity promoted AP-1 (activator protein-1) binding to DNA, supporting a function for transporter signalling in retinal long-term responses. These results add a novel receptor-independent pathway for Glu signalling in Müller glia, and further strengthen the critical involvement of these cells in the regulation of glutamatergic transmission in the retina.

INTRODUCTION

Glu (glutamate), the main excitatory neurotransmitter in the radial signalling pathway of the vertebrate retina (Massey and Miller, 1990), regulates proliferation, migration and survival of neuronal progenitors and immature neurons (Guerrini et al., 1995). It also plays a key role in the regulation of gene expression required for physiological adaptive processes, including synaptic plasticity (Thomas and Huganir, 2004; Wang et al., 2007).

The ability of Glu to drive a diversity of functions relates to its interaction with a wide variety of receptor subtypes and transporters that act independently or in combination to attain differential responses. Glutamatergic activity is mediated by iGluRs (ionotropic receptors) and mGluRs (G-protein-coupled metabotropic receptors). The superfamily of iGluRs includes the Na⁺- or Ca²⁺-permeable cation channels NMDA (N-methyl-D-aspartate), AMPA (α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) and KA (kainite) receptors. Eight mGluRs, linked to the activation of second messenger cascades, have been identified (Michaelis, 1998), coupled to the stimulation of phospholipase C and the release of intracellular Ca²⁺ (Group I), or to the inhibition of adenylyl cyclase (Groups II and III) (Coutinho and Knopfel, 2002).

Glia cells respond to neurotransmitters through the activation of specific receptors and intracellular pathways, which directly or indirectly modify the neuronal activity (Fields and Stevens-Graham, 2002). Among its functions, MGC (Müller glia cells), the main type of retinal glia, are responsible for potassium homoeostasis, lactate supply to neurons, pH regulation and neurotransmitter removal (Hollander et al., 1991; Lopez-Colome and Romo-de-Vivar, 1991; Rauen and Kanner, 1994; Lopez et al., 1997; Bringmann et al., 2009).

Owing to their close apposition to synaptic contacts in both plexiform layers of the retina, MGC are exposed to synaptically released Glu, and are involved in the recycling of Glu through the Glu/glutamine neuron–glia shuttle, which provides Glu supply to the presynaptic terminals. Also along this line, the activation of Glu receptors in Müller cells feeds back on to neurons by triggering the release of neuroactive compounds (Uchihori and Puro, 1993; Lopez-Colome et al., 1995; Lopez et al., 1998; Lopez-Bayghen et al., 2006).

mTOR (mammalian target of rapamycin), now officially known as mechanistic TOR, is a protein kinase involved in the regulation of a wide range of cellular processes including protein synthesis, gene transcription, the cell cycle and autophagy (Proud, 2007; Laplante and Sabatini, 2012), and it has been implicated in cancer and other diseases, as well as in the control of lifespan and aging (Blagosklonny, 2010). mTOR forms the catalytic core of two different complexes: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) that differ in composition; while complex 1 contains raptor, complex 2 is composed of rictor, Sin1 and protor. Both complexes contain mLST8 (Wang and Proud, 2011). mTORC1 but not mTORC2 is inhibited by a low concentration of the macrolide rapamycin; in an over-simplified scenario, mTORC1 mediates the mTOR effects that are rapamycin-sensitive. An accepted index of mTOR activation is Ser-2448 phosphorylation as the result of a signalling cascade involving PI3K (phosphoinositide 3-kinase), PDK1 (phosphoinositide-dependent kinase 1), mTORC2 and PKB/Akt (protein kinase B), which can phosphorylate mTORC1 (Foster and Fingar, 2010). Phosphorylated mTORC1 acts on p70^S6K (70 kDa S6 ribosomal kinase), 4E-BP (4E-binding protein), eEF2K (eukaryotic elongation factor 2 kinase) and eEF1A (eukaryotic elongation factor 1A), increasing translation. It should be noted that p70^S6K also phosphorylates mTOR at Ser-2448, which is assumed to be an additional level of mTOR regulation (Rosner and Hengstschlager, 2010).

Glu concentration at the synaptic cleft requires tight regulation in order to avoid excitotoxic neuronal death (Mattson, 2003; Olney, 2003). Such regulation is accomplished through the removal of Glu by a family of Na⁺-dependent transporters expressed in neurons and glia (Danbolt, 2001). To date, five subtypes of transporters known as EAAT1–5 (excitatory amino acids transporters 1–5) have been reported. The glia transporters EAAT-1 [GLAST (Na⁺-dependent glutamate/aspartate transporter)] and EAAT-2 (GLT-1) are responsible for more than 90% of the Glu uptake in the brain. In the retina, although the expression of EAAT-4 has been reported (Fyk-Kolodziej et al., 2004), GLAST, located in Müller cells, is the predominant transporter responsible for Glu reuptake (Gadea et al., 2004).

Evidence has accumulated suggesting that Glu transporters might be involved in intracellular signalling. In fact, Glu and transportable blockers down-regulate Glu uptake in a receptor-independent manner (Gonzalez and Ortega, 2000; Gadea et al., 2004). Furthermore, the coupling of GLAST/EAAT-1 activity to the Na⁺/K⁺ ATPase in astrocytes (Gegelashvili et al., 2007; Rose et al., 2009) and to the promotion of mTOR phosphorylation in cerebellar glia (Zepeda et al., 2008) has also been reported.

Dysfunction of EAATs is specifically involved in excitotoxic neuronal death under pathological neurodegenerative conditions and ischaemic stroke injury, characterized by the elevation of extracellular Glu. Hence, the characterization of signalling mechanisms activated by transporter function may provide tools for the modulation of EAAT function under pathological conditions.

In order to provide evidence for GLAST/EAAT-1-mediated Glu signalling in the vertebrate retina, we analysed transporter-dependent mTOR phosphorylation in primary cultures of chick MGC. Our results show that GLAST activity triggers Ca²⁺ influx, and increases mTOR phosphorylation and AP-1 (activator protein-1) DNA-binding activity, suggesting that Glu imbalance could alter the translation of proteins involved in gene regulation in the retina.

MATERIALS AND METHODS

Materials

Tissue culture reagents were obtained from GE Healthcare. Wortmannin, amiloride [3,5-diamino-6-chloro-N-(diaminomethylene)pyrazine-2-carboxamide], PP2 {4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine}, W7 [N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide], AMPA, KA acid, NMDA, CNQX (6-cyano-7-nitroquinoxaline-2,3-dione), DL-TBOA (DL-threo-b-benzyloxyaspartic acid), THA (threo-β-hydroxyaspartate), D-Asp and Glu were all obtained from Tocris-Cookson. ⁴⁵Ca²⁺ and [α³²P]dATP was from PerkinElmer. Polyclonal anti-phospho-mTOR (Ser-2448) and anti-mTOR antibodies (05-235) were purchased from Cell Signalling Technology. Anti-phospho-p60^src (Tyr-527) was obtained from Abcam. Horseradish peroxidase-linked anti-rabbit antibodies and the enhanced chemiluminescence reagent (ECL) were obtained from Amersham Biosciences. PDC (L-trans-pyrrolidine-2,4-dicarboxylic acid), T3MG [(±)-threo-3-methylglutamic acid] and all other chemicals were purchased from Sigma.

Cell culture and stimulation protocol

Primary cultures of retina MGC were prepared from 7-day-old chick embryos as previously described (Lopez-Colome et al., 1993). The cells were plated in 6- or 24-well plastic culture dishes in OptiMEM containing 4% foetal bovine serum, 2 mM glutamine and gentamicin (50 μg/ml) and used on the 10th to the 12th day in the culture. Before any treatment, confluent monolayers were serum-deprived with 0.5% bovine serum albumin in OptiMEM for 30 min and then treated as indicated. Inhibitors were included 30 min prior to agonist addition. Glu and its analogues were added to the medium for the indicated time periods; following treatment, the medium was replaced by 0.5% albumin/OptiMEM.

SDS/PAGE and Western blots

Cells from confluent monolayers were harvested in PBS (phosphate-buffered saline) (10 mM K₂HPO₄/KH₂PO₄, 150 mM NaCl, pH 7.4) containing phosphatase inhibitors (10 mM NaF, 1 mM Na₂MoO₄ and 1 mM Na₃VO₄). The cells were lysed with RIPA buffer (50 mM Tris/HCl, 1 mM EDTA, 150 mM NaCl, 1 mM PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin, 1% NP-40, 0.25% sodium deoxycolate, 10 mM NaF, 1 mM Na₂MoO₄ and 1 mM Na₃VO₄, pH 7.4). Cell lysates were denatured in Laemmli's buffer, and proteins resolved by SDS/PAGE (6–10% gel) and electroblotted on to nitrocellulose membranes. Blots were stained with Ponceau S to confirm that protein content was equal in all lanes. Membranes were soaked in PBS to remove the Ponceau S and incubated in 50 mM Tris/HCl, pH 7.4, and 150 mM NaCl (TBS) containing 5% dried skimmed milk and 0.1% Tween 20 for 60 min to block the excess of non-specific protein binding sites. The membranes were then incubated overnight at 4°C with the primary antibodies indicated in each Figure, followed by the corresponding secondary antibodies. Immunoreactive polypeptides were detected by chemiluminescence and exposed to X-ray films. Densitometric analyses were performed and data were analysed with Prism from GraphPad Software.

⁴⁵Ca²⁺ Influx

Confluent MGC monolayers seeded in 24-well plates were washed three times to remove all non-adhering cells with 0.5 ml aliquots of solution A containing 25 mM Hepes/Tris, 130 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl₂, 0.8 mM MgCl₂, 33.3 mM glucose and 1 mM NaH₂PO₄ at pH 7.4. The Glu- or D-Asp-induced ⁴⁵Ca²⁺ influx was initiated at t=0 by the addition of 0.5 ml of solution A containing 1.5 μCi of ⁴⁵Ca²⁺/ml solution A, Glu or D-Asp at a given concentration. When tested, inhibitors or modulators were included 30 min prior to the addition of ⁴⁵Ca²⁺. The reaction was stopped by aspirating the radioactive medium and washing each well within 15 s with 0.5 ml aliquots of an ice-cold solution A. The cells were digested in 0.5 ml of 1 M NaOH for 2 h at 37°C. The radioactivity contained in each fraction was determined using a Beckmann 7800LS scintillation counter in the presence of a scintillation cocktail. All experiments were performed in triplicate.

EMSAs (electrophoretic mobility-shift assays)

After the stimulation period, the cells were shifted to complete culture media for 1 h and nuclear extracts were prepared as described previously (Zepeda et al., 2008). All the buffers contained a protease inhibitor cocktail to prevent nuclear factor proteolysis. Protein concentration was measured using the Bradford method. Nuclear extracts (approximately 20 μg) from control or treated MGC were incubated on ice with 500 ng of poly[(dI-dC)] as non-specific competitor (LG Healthcare) and 1 ng of [³²P]-end labelled double-stranded AP-1 (SV40) oligonucleotide: 5′-CTAGTTCCGGCTGAGTCATCAAGC-3′

The reaction mixtures were incubated for 20 min on ice, and the proteins were separated by electrophoresis in SDS/PAGE (6% gels) in a low ionic strength 0.5X TBE buffer. The gels were vacuum-dried and exposed to an auto-radiographic film overnight.

Statistical analysis

Data are expressed as the mean (average)±standard error (S.E.). A one-way analysis of variance (ANOVA) (Kruskal–Wallis test) and Dunn's post-hoc test were performed to determine significant differences between conditions with the Prism software.

RESULTS

Glu- and D-Asp-induced mTOR phosphorylation in MGCs

mTOR is a fundamental kinase involved in translational control, the fine-tuning process of gene expression. As Glu is known to modify this process, we investigated a possible Glu transport-mediated change in mTOR phosphorylation pattern in retinal MGC. As depicted in Figure 1(A), inclusion of 1 mM Glu induced a fast time-dependent increase in Ser-2448 mTOR phosphorylation, reaching a maximal value at 15 min. No apparent changes in mTOR levels were observed in this condition. The results presented in Figure 1(B) show that a time-dependent increase in mTOR phosphorylation by Glu was also induced by 1 mM D-Asp. The return of mTOR phosphorylation to basal levels in both conditions suggests a Glu- or D-Asp-dependent p70^S6K dephosphorylation that through a feedback loop would decrease mTOR Ser-2448 phosphorylation (Harrington et al., 2004; Um et al., 2004; Rosner and Hengstschlager, 2010).

Figure 1

(A) MGC were treated with 1 mM Glu for the indicated time periods, and the level of total and Ser-2448 phosphorylated mTOR were analysed by Western blot as described in the Materials and methods section. (B) Confluent MGC monolayers were treated with 1 mM D-Asp for the indicated time periods. The level of mTOR phosphorylation was determined as described for (A). (C) Müller glia cultures were exposed for 15 min to increasing D-Asp concentrations; the EC₅₀ was calculated from the densitometric analysis using the Prism program (GraphPad). (D) Cells were incubated for 15 min with vehicle (NS), Glu (1 mM) or the Glu analogues AMPA (1 mM), KA (1 mM), NMDA (1 mM) plus 10 μM glycine (NMDA/Gly), and D-Asp (1 mM). The results are presented as the mean ±S.E. of at least three independent experiments. In each panel, a representative Western blot is shown. Statistical analysis was performed comparing against non-stimulated cells using a non-parametric one-way ANOVA (Kruskal–Wallis test) and Dunn's post-hoc test (*P<0.05, ***P<0.001).

Exposure of MGC cultures to increasing concentrations of D-Asp for 15 min reveals a clear dose-dependency with an apparent EC₅₀ of 15.2 μM (Figure 1C), indicating the specificity of the effect. It should be noted that this value is only indicative of a receptor/transporter-mediated effect, as it does not take into consideration the amplification inherent to signalling cascades (Kholodenko, 2006).

In order to discard the contribution of Glu receptors to the observed effects, the cells were treated with 1 mM of the specific ionotropic receptor agonists: AMPA, KA and NMDA plus glycine (10 μM). A discrete non-significant increase in mTOR phosphorylation by AMPA and KA was detected (Figure 1D), suggesting that the transporter activity is responsible for most, if not all, of the Glu-induced mTOR phosphorylation.

In order to confirm these results, MGC were treated for 30 min, prior to D-Asp or THA addition, with 50 μM of the non-NMDA iGluR antagonist CNQX (Figure 2A), the NMDA receptor antagonist MK-801, the group I mGluR antagonist LAP5, or with CPCCOEt, the group II/III mGluR antagonist (Figures 2B and 2C). The results showed that Glu receptor antagonists failed to block the increase in mTOR phosphorylation induced by D-Asp or THA, further supporting the fact that the effect of Glu on mTOR is mainly transporter-mediated. Moreover, as D-Asp does not activate Glu receptors, the lack of a statistically significant difference between the Glu- and D-Asp-induced effects further indicates that mTOR phosphorylation is transporter-mediated.

Figure 2

In all panels phosphorylated mTOR was detected as described for Figure 1. (A) MGC monolayers were incubated for 15 min with Glu (1 mM), THA (100 μM), the AMPA receptor antagonist CNQX (50 μM), and CNQX plus THA, in this case CNQX was added 30 min prior to THA treatment (100 μM, 15 min). MGC cultures were pre-exposed to NMDA receptor antagonists MK-801 (5 μM) or LAP5 (10 μM) (B) and to metabotropic Glu receptors antagonists, for group I CPCCOEt (100 μM) and for group II/III CPPG (300 μM) (C), 30 min prior to D-Asp treatment (1 mM, 15 min). Data are expressed as the mean ±S.E. of at least three independent experiments. Representative Western blots are shown for each condition. Statistical analysis was performed comparing against non-stimulated cells using a non-parametric one-way ANOVA (Kruskal–Wallis test) and Dunn's post-hoc test (*P<0.05, ***P<0.001).

GLAST/EAAT-1-dependent mTOR phosphorylation

In order to directly confirm that the D-Asp-induced increase in mTOR phosphorylation relies on GLAST/EEAT-1 transport activity, the effect of transportable and non-transportable GLAST inhibitors was analysed. As shown in Figure 3(A), D-Asp-induced increase in mTOR phosphorylation was mimicked by 100 μM of the transportable inhibitors THA and PDC. In contrast, the non-transportable inhibitor TBOA (100 μM) had no effect. As the expression of EAAT-4 in MGC has been recently reported (Fyk-Kolodziej et al., 2004), we evaluated the involvement of this transporter in mTOR phosphorylation. As clearly shown in Figure 3(B), pretreatment with the specific EAAT-4 blocker T3MG did not alter the D-Asp response, ruling out the participation of EAAT-4.

Figure 3

(A) MGC monolayers were incubated for 15 min with vehicle (NS), Glu (1 mM), D-Asp (1 mM) or EAAT blockers, THA (100 μM), TBOA (100 μM) and PDC (100 μM), and the levels of Ser-2448 phosphorylated mTOR and total mTOR were detected via Western blots. (B) Cultured cells were treated with EAAT-4 blocker T3MG (200 μM) or TBOA (100 μM) for 30 min, prior to the addition of 1 mM D-Asp for 15 min, DMSO (0.01%) was used as a vehicle control. (C) MGC monolayers were exposed to vehicle (NS), D-Asp (1 mM) or THA (100 μM), in complete or Na⁺-free assay buffer and then the phosphorylation of mTOR was analysed. (D) Levels of Thr 70 phosphorylated 4E-BP were detected after treatment with 1 mM D-Asp or 100 μM THA in the presence or absence of 100 nM rapamicin (RAPA) for 30 min; actin was used as loading control. Data are expressed as the mean±S.E. of at least three independent experiments. Representative Western blots are shown for each condition. Statistical analysis was performed comparing against non-stimulated cells using a non-parametric one-way ANOVA (Kruskal–Wallis test) and Dunn's post-hoc test (*P<0.05, ***P<0.001).

If, indeed, the effect of D-Asp and THA is mediated by GLAST activity, it should be abolished in the Na⁺-free medium. As clearly shown in Figure 3(C), mTOR phosphorylation was completely prevented by substituting choline chloride for NaCl, clearly demonstrating the involvement of Na⁺-dependent transport in this process. In order to provide evidence for transporter-mediated mTOR activation, we explored the phosphorylation of one of its substrates, 4E-BP; the results are shown in Figure 4(D). Exposure of the cultured cells to D-Asp or THA results in a rapamycin-sensitive increase in 4E-BP phosphorylation.

Figure 4

mTOR phosphorylation was detected as for Figure 1. (A) Monolayers were incubated in normal or Ca²⁺-free medium supplemented with EDTA (500 μM, 30 min), and then treated with D-Asp (1 mM) or THA (100 μM) for 15 min. (B) MGC were stimulated with D-Asp (1 mM, 15 min) in the presence or absence of the Na⁺/Ca²⁺ exchanger inhibitors amiloride (10 μM) or KB-R7943 (15 μM) added 30 min prior to D-Asp treatment. (C) MGC monolayers were pretreated (30 min) with the calmodulin antagonist, W7 (25 μM) prior treatment with D-Asp (1 mM, 15 min). The results are the mean ±S.E. of at least three independent experiments. In each panel a representative Western blot is shown. Statistical analysis was performed comparing against non-stimulated cells using a non-parametric one-way ANOVA (Kruskal–Wallis test) and Dunn's post-hoc test (*P<0.05, ***P<0.001).

GLAST-induced mTOR phosphorylation is Ca²⁺-dependent

Intracellular Na⁺ increase driven by GLAST may activate Na⁺/Ca²⁺ exchange, leading to an increase in intracellular Ca²⁺ concentration. In order to assess the Ca²⁺-dependence of the GLAST response, the cells were treated with D-Asp or THA in Ca²⁺-free medium supplemented with 500 μM EDTA. As shown in Figure 4(A), removal of extracellular Ca²⁺ fully prevented the GLAST effect on mTOR phosphorylation. These results demonstrate that GLAST-mediated mTOR phosphorylation requires Ca²⁺ influx. As a possible mechanism linking transporter activity to Ca²⁺ entry, the activation of the Na⁺/Ca²⁺ exchanger by GLAST-mediated Na⁺ influx was explored using the inhibitors amiloride and KB-R7943. The results in Figure 4(B) show that both compounds prevented D-Asp-induced mTOR phosphorylation. Since calmodulin is the main Ca²⁺ intracellular receptor, its possible participation in GLAST induction of Ca²⁺-dependent mTOR activation was explored. The results in Figure 4(C) show that 25 μM of the calmodulin antagonist W7 fully prevented the D-Asp response. Collectively, these data indicate that the D-Asp increase in mTOR phosphorylation is achieved through the entry of Na⁺ as a result of GLAST activity and the consequent activation of the Na⁺/Ca²⁺ exchanger, which, in turn, increases the intracellular Ca²⁺ that binds to calmodulin.

GLAST-induced ⁴⁵Ca²⁺ influx

To further confirm this conclusion, confluent MGC cultures were exposed to a 1 mM D-Asp solution containing 1 μCi/ml ⁴⁵Ca²⁺ for various time periods. As shown in Figure 5(A), D-Asp induced a fast time-dependent influx of ⁴⁵Ca²⁺, which saturated at 3 min. As expected, removal of extracellular Na⁺ ions prevents the D-Asp-induced ⁴⁵Ca²⁺ influx (Figure 5B). A fixed 10 μM concentration of the Ca²⁺ionophore A23187, as well as THA and PDC, also evoked significant entry of the radioactive ion (Figure 5C). In contrast, the non-transportable GLAST inhibitor TBOA did not induce ⁴⁵Ca²⁺ influx (Figure 5D). The EAAT-4 blocker T3MG failed to prevent the D-Asp-evoked response (Figure 5E). Furthermore, the Na⁺/Ca²⁺ exchanger specific inhibitor KB-R7943 prevented the D-Asp-triggered increase in ⁴⁵Ca²⁺ influx (Figure 5F), clearly indicating a transporter-induced effect. To rule out the participation of the L-type voltage-gated Ca²⁺ channels (VGCC), confluent MGC cultures were pre-incubated with 10 μM nifedipine and the effect of D-Asp measured. As shown in Figure 5(G), pre-incubation with nifedipine did not modify the D-Asp-dependent Ca²⁺ influx.

Figure 5

(A) MGC were incubated with 1 mM D-Asp at room temperature, and ⁴⁵Ca²⁺ uptake was measured at the indicated time periods (0, 0.5, 1, 1.5, 2 and 3 min). (B) Monolayers were incubated in complete or Na⁺-free assay buffer and treatment with Glu (1 mM), D-Asp (1 mM) or THA (100 μM). (C) ⁴⁵Ca²⁺ influx was determined in the presence of 1 mM D-Asp, 100 μM THA, 100 μM TBOA or 100 μM PDC. The Ca²⁺ ionophore A23187 (10 μM) was used as a positive control. All drugs were included for 3 min. (D) Cells were pre-exposed for 30 min to the non-transportable Glu transport blocker TBOA 100 μM and then to D-Asp 1 mM and THA 100 μM, the influx time was 3 min. (E) MGC were incubated with TBOA (100 μM) or EAAT-4 blocker T3MG (200 μM) for 30 min prior the D-Asp treatment and then ⁴⁵Ca²⁺ uptake was measured. (F) Monolayers were pre-incubated (30 min) in presence or absence of KB-R7943 (15 μM) and treatment with D-Asp (1 mM). (G) MGC were pre-incubated for 30 min with the L-type VGCC blocker nifedipine (NIFE, 10 μM), and then exposed to 1 mM D-Asp. The Ca²⁺ ionophore A23187 10 μM was used as a positive control. The different drugs were present during the 3 min of ⁴⁵Ca²⁺ influx. Values represent the mean ±S.E. of at least three independent experiments performed in triplicate. Statistical analysis was performed comparing against non-stimulated cells using a non-parametric one-way ANOVA (Kruskal–Wallis test) and Dunn's post-hoc test (*P<0.05, ***P<0.001).

Intracellular signalling involved in GLAST-mediated mTOR phosphorylation

To establish the molecular signalling cascade involved in GLAST-mediated mTOR phosphorylation, we first explored the participation of PI3K, known to act upstream of mTOR in several systems. Pretreatment of MGC for 15 min with 10 nM of the PI3K inhibitor wortmannin, completely prevented the increase in mTOR phosphorylation induced by either D-Asp or THA (Figure 6A).

Figure 6

MGC were pre-incubated for 30 min with 10 nM of the PI3K inhibitor wortmannin (Wort) (A), with 100 nM of the PKB inhibitor (PKBI-IV) (B), or the p60^src inhibitor PP2 (10 nM) in the absence or presence of the RTK inhibitor genistein at 25 μM (C); and then treated with D-Asp (1 mM) or THA (100 μM). Levels of mTOR phosphorylation were detected as for Figure 1. (D) Levels of Tyr-527 phosphorylated p60^src were detected after treatment with 1 mM D-Asp in the presence/absence of W7 (25 μM) or genistein (25 μM). Phospho-p60^src levels were analysed by Western blot, Ponceau S was used as a loading control. The results are the mean ±S.E. of at least three independent experiments. In each panel, a representative Western blot is shown. Statistical analysis was performed comparing against non-stimulated cells using a non-parametric one-way ANOVA (Kruskal-Wallis test) and Dunn's post-hoc test (*P<0.05, ***P<0.001).

The phosphorylation of membrane phosphatidylinositol at the C3-OH position of the inositol ring by PI3K is known to anchor proteins containing PH (pleckstrin homology) domains (Harrington et al., 2004), such as PKB. The results in Figure 6(B) demonstrate that 100 nM of the PKB inhibitor PKBI-IV was capable of preventing the GLAST-mediated effect, indicating the involvement of PKB, downstream of PI3K, in GLAST-dependent mTOR phosphorylation.

Activation of PI3K involves the docking of the regulatory subunit of PI3K to a phosphorylated tyrosine residue (Vanhaesebroeck and Alessi, 2000). We evaluated the possible involvement of the Src (non-receptor tyrosine kinase p60^src) in GLAST signalling. As clearly shown in Figure 6(C), MGC pretreatment with 10 nM of the specific Src inhibitor PP2, prevented the D-Asp effect on mTOR. Since Src activation requires Tyr-527 in a dephosphorylated state, we examined the phosphorylation level of this residue in D-Asp-stimulated MGC and showed that, indeed, D-Asp treatment sharply reduced Tyr-527 p60^src phosphorylation levels (Figure 6D). This result suggested the participation of an RTK (receptor tyrosine kinase) upstream of Src in GLAST-mediated mTOR phosphorylation. In order to explore this possibility, the effect of the RTK inhibitor genistein (25 μM) was tested. As expected, genistein was capable of preventing the effect of D-Asp (Figure 6D), suggesting a p60^src-dependent RTK trans-phosphorylation.

GLAST activity signalling-dependent transcriptional control

Glu stimulation has been linked to transcriptional control in glial cells (Lopez-Bayghen et al., 2006). Following the demonstration of GLAST-induced Ca²⁺-dependent activation of the translation regulator mTOR, the possible induction of gene transcription by this process was analysed. We investigated if GLAST activity induced by D-Asp and THA results in increased DNA binding of the inducible transcription factor AP-1, known to be Ca²⁺-dependent in MGC (Lopez-Colome et al., 1995). The results presented in Figure 7(A), clearly show that D-Asp as well as Glu and THA increase GLAST-mediated AP-1 DNA-binding activity in Müller cells. In order to explore the participation of Na⁺/Ca²⁺ exchanger in transcriptional regulation, the effects of the Na⁺/Ca²⁺ exchanger inhibitor (KB-R7943) and of the calmodulin antagonist W7 were determined. The results shown in Figure 7(B) clearly demonstrate that Na⁺/Ca²⁺ exchanger and calmodulin participates in the transcriptional regulation mediated by GLAST.

Figure 7

(A) EMSAs. Nuclear extracts were prepared from control or treated cells (Glu, D-Asp, THA or TBOA) and binding to the AP-1 consensus sequence was analysed as described in the Materials and methods section. (B) Nuclear extracts were prepared from cells pre-incubated 30 min with Na⁺/Ca²⁺ exchanger inhibitor (KB-R7943, 15 μM) and with the calmodulin antagonist (W7, 25 μM), after that treated with D-Asp (1 mM, 90 min) the binding to the AP-1 consensus sequence was analysed. The results are the mean ±S.E. of at least three independent experiments. Statistical analysis was performed comparing against non-stimulated cells using a non-parametric one-way ANOVA (Kruskal–Wallis test) and Dunn's post-hoc test (*P<0.05, ***P<0.001).

DISCUSSION

Traditionally regarded as supportive and passive elements, glia cells have proven to be critically involved in glutamatergic transmission (Eulenburg and Gomeza, 2010). The participation of glia cells in the control of excitatory transmission through the so-called Glu/glutamine shuttle, which replenishes releasable Glu stores in neurons, has been recognized for more than 25 years (Shank and Campbell, 1984). Furthermore, an energetic neuronal dependence on astrocytes has also been described for glutamatergic synapses (Pellerin, 2008). In spite of the fact that most Glu receptors are expressed in glia cells (D'Antoni et al., 2008), the availability of Glu for inter-neuronal and neuron–glia interactions relies on an efficient Glu uptake activity. It is therefore conceivable that transporters may contribute to Glu signalling, particularly in glia cells. In this context, we have described the regulation of Glu removal in radial glia cells by a transporter-mediated process involving the regulation of GLAST/EAAT-1 membrane expression (Gonzalez and Ortega, 2000; Gadea et al., 2004). More recently, the group of Hampson have demonstrated a direct coupling of Glu transporters to the Na,K-ATPase in glia cells (Rose et al., 2009). In such a scenario, it is tempting to speculate that intracellular signalling activated by Glu transporters could be linked to the long-term regulation of glia–neuronal reciprocal interactions in excitatory transmission.

The results from this study clearly show that the transport process itself triggers a signal transduction cascade involving the activation of p60^src, PI3K and PKB (Akt) linked to extracellular Ca²⁺ entry, which leads, not only to the promotion of translation by Ser-2448 phosphorylated mTOR, but also to transcriptional activity mediated by Ca²⁺-dependent binding of inducible transcription factors, such as the AP-1. In this regard, the activation of CaMKII induces the phosphorylation/activation of RTKs which, in turn, allows PI3K membrane anchoring and activation (Wang and Proud, 2011). We show here, that Ca²⁺ entry promoted by GLAST activity induces a transient mTOR phosphorylation through p60^src/PI3K/Akt/mTOR/p70^S6K signalling. It is quite possible that the Ca²⁺ signal activates phosphatase 2A that would dephosphorylate and inactivate p70^S6K, thus reducing mTOR Ser-2448 phosphorylation giving up the transient nature of the effect (Nunbhakdi-Craig et al., 2002). Furthermore, as CaMKII has been shown to activate the expression of c-fos through the MAPK MEK/ERK cascade in Müller glia, the proposed GLAST signalling cascade is supported by the increase in AP-1 binding (Abe and Saito, 2001; Takeda et al., 2002).

As mTOR has been regarded as a master regulator of protein synthesis (Foster and Fingar, 2010) and AP-1 DNA binding is critical for the transcriptional control of a number of genes (Shaulian, 2010), it is possible that the removal of Glu from the synaptic cleft is linked to gene expression regulation in glia cells. A working hypothesis is that specific genes, such as those coding for the Glu transporters, the Na⁺/K⁺-ATPase, glutamine synthetase or the neutral amino acid transporters could be the targets of GLAST-dependent gene expression regulation, and could participate actively in glia–neuronal coupling. Work currently in progress in our group is aimed at the identification of these genes. Taking into consideration that mTOR is not only a transducing molecule for mitogenic signals, but also for nutrient availability correlated with protein synthesis for housekeeping glial functions, transporter signalling to mTOR and gene expression could play a role in linking these responses (towards cell division).

The functional significance of signalling through the transporters compared with the cascades activated via Glu receptors, and the fact that both would lead to gene expression regulation in glia cells (Lopez-Bayghen et al., 2006), is elusive at this point. Yet, it is conceivable that the difference in the kinetics of activation, favoured by lower affinity of the transporters and their higher density (Danbolt, 2001), is the basis for a transporter-selective response at the level of transcriptional and/or translational control. Yet another possibility is that an activity-dependent differential distribution of transporters and receptors in detergent-resistant membrane domains and the inclusion or not of differential signalling partners constitutes the molecular basis of the existence of transporter-mediated signal transduction (Butchbach et al., 2004; Gonzalez et al., 2007; Hou et al., 2008).

In summary, we demonstrated here that Glu transport in MGC is linked to the activation of signal transduction cascades that lead to gene expression regulation. A description of our present findings is summarized in Figure 8. Our results further strengthen the pivotal role of glia cells in glutamatergic transmission in the retina.

Figure 8

Glu uptake leads to an influx of Na⁺ that activates the Na⁺/Ca²⁺ exchanger, resulting in a net Ca²⁺ influx. The elevation of intracellular Ca²⁺ leads to the up-regulation of c-fos transcription and the promotion of AP-1 DNA-binding activity. On the other hand, Ca²⁺ entry results in p60^src Tyr-527 dephosphorylation and Trk transactivation, the recruitment and activation of PI3K and Akt/PKB, which, in turn, results in mTOR phosphorylation and an increase in mRNA translation.